Evidence map›Paper›PMID 39112604›Full record

ArticleScientific reports2024

Five-year follow-up after a single US-guided high intensity focused ultrasound treatment of breast fibroadenoma.

B Boeer, E Oberlechner, R Rottscholl, I Gruber, S Guergan, S Brucker, M Hahn

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

B BoeerDepartment of Women's Health, University Hospital of Tuebingen, Calwerstraße 7, 72076, Tübingen, Germany. bettina.boeer@med.uni-tuebingen.de.
E OberlechnerDepartment of Women's Health, University Hospital of Tuebingen, Calwerstraße 7, 72076, Tübingen, Germany.
R RottschollDepartment of Pathology, University Hospital of Tuebingen, Tübingen, Germany.
I GruberDepartment of Women's Health, University Hospital of Tuebingen, Calwerstraße 7, 72076, Tübingen, Germany.
S GuerganDepartment of Women's Health, University Hospital of Tuebingen, Calwerstraße 7, 72076, Tübingen, Germany.
S BruckerDepartment of Women's Health, University Hospital of Tuebingen, Calwerstraße 7, 72076, Tübingen, Germany.
M HahnDepartment of Women's Health, University Hospital of Tuebingen, Calwerstraße 7, 72076, Tübingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the long-term efficacy of a single ultrasound-guided high-intensity focused ultrasound (US-HIFU) treatment in patients with breast fibroadenoma (FA) in terms of volume and pain reduction as well as palpation findings. From december 2013 until november 2014 27 women with a symptomatic FA were treated in one HIFU-session. Follow-up visits were performed after 7 days, 6 months and 1, 2, 3 and 5 years with clinical examination and ultrasound. One year after the procedure, a core needle biopsy of the residual lesion was offered. There was a significant volume reduction 6 months after HIFU from 1083.10 to 347.13 mm

Indexed as

Breast NeoplasmsFibroadenomaHigh-Intensity Focused Ultrasound AblationAdultFemaleFollow-Up StudiesHumansMiddle AgedTreatment OutcomeYoung AdultBreast fibroadenomaThermal ablationUS-guided high-intensity focused ultrasound (US-HIFU)

Identifiers

PMID39112604
PMCPMC11306253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.